We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Generic Nizatidine Antacid Wins Approval for Amneal
Generic Nizatidine Antacid Wins Approval for Amneal
December 9, 2009
Amneal Pharmaceuticals has received FDA approval to market the first generic nizatidine oral solution to treat heartburn, gastroesophageal reflux disease
and conditions associated with excess acid secretion.